New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A1833

Introduced
1/9/24  

Caption

Requires notice of motor vehicle safety recalls upon inspection and registration of motor vehicle; requires motor vehicle manufacturers to pay annual fee to MVC.

Impact

The implementation of Bill A1833 has the potential to significantly enhance road safety in New Jersey. By ensuring that vehicle owners receive timely and clear information regarding safety recalls, the bill not only encourages compliance with necessary repairs but also seeks to reduce the number of vehicles operating with known safety issues. This proactive approach is expected to mitigate risks associated with vehicle recalls, thus contributing to overall public safety on New Jersey roads.

Summary

Bill A1833 mandates that motor vehicle inspection facilities in New Jersey provide written notice to vehicle owners regarding any open safety recalls during the inspection process. This includes details about each open recall and indicates that repairs for these recalls can be completed at approved dealerships at no cost to the owner, barring certain exceptions. The bill seeks to enhance vehicle safety by ensuring that owners are aware of and address outstanding safety issues before they can renew their vehicle's registration. In addition to inspection procedures, A1833 requires the New Jersey Motor Vehicle Commission (MVC) to notify vehicle owners of any applicable recalls when the vehicle is registered or during registration renewal. Under this law, owners are obligated to complete necessary repairs for any open recalls before renewing their registration. Failure to do so will result in the MVC denying the registration renewal request, thus preventing vehicles with unresolved safety issues from being driven legally on public roads. The bill also includes provisions for situations where repair parts may be unavailable. In such cases, the chief administrator has the authority to grant extensions for registration renewal for six-month intervals. Additionally, if an owner faces undue hardship that prevents them from making repairs, a further discretionary extension for up to six months may be granted. This flexibility is significant as it helps protect vehicle owners who may face difficulties in accessing necessary repairs. A key aspect of the bill is its limitation on liability for individuals and entities involved in the notice process regarding open recalls. The chief administrator, employees of the MVC, and private inspection facilities are shielded from liability for actions related to proving open recall notices, unless they exhibit gross negligence. Overall, A1833 aims to tighten regulations around vehicle safety recalls, ensuring that all motorists are informed and compliant with safety requirements.

Companion Bills

NJ A2019

Carry Over Requires notice of motor vehicle safety recalls upon inspection and registration of motor vehicle; requires motor vehicle manufacturers to pay annual fee to MVC.

NJ S2004

Carry Over Requires notice of motor vehicle safety recalls upon inspection and registration of motor vehicle; requires motor vehicle manufacturers to pay annual fee to MVC.

Similar Bills

NJ S2004

Requires notice of motor vehicle safety recalls upon inspection and registration of motor vehicle; requires motor vehicle manufacturers to pay annual fee to MVC.

NJ A2019

Requires notice of motor vehicle safety recalls upon inspection and registration of motor vehicle; requires motor vehicle manufacturers to pay annual fee to MVC.

NJ S359

Requires notice of motor vehicle safety recalls upon registration of motor vehicle; requires motor vehicle manufacturers to pay fee to MVC in certain circumstances.

NJ A4008

Requires notice of motor vehicle safety recalls upon inspection and registration of motor vehicle; requires motor vehicle manufacturers to pay annual fee to MVC in certain circumstances.

NV SB40

Revises provisions related to manufactured housing. (BDR 43-270)

NJ A3621

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

NJ S1667

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

NJ A2240

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.